RxDoctor Payments Data

Sam Miller

Endocrinology, Diabetes & Metabolism · San Antonio, TXNPI 1184796047

Payments from drug & device makers

$628,815in general payments, 2019–2025

Across 136 payments — averaging $4623.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi US Services Inc.$539K
  • Astrazeneca UK Limited$41K
  • Novartis$15K
  • E.r. Squibb & Sons, L.L.C.$12K
  • Radius Health, Inc.$11K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$6K
  • plus $4K from 4 others
$1,568in research payments, 2019–2025

Across 2 payments — averaging $784.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$2K

What the payments were for

  • Food & beverage$33100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$628,815 in reported general payments places this provider in the 90th percentile of 658 endocrinology, diabetes & metabolism providers in Texas.

See all endocrinology, diabetes & metabolism providers in Texas

Other endocrinology, diabetes & metabolism in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →